Michalina Janiszewska
Overview
Explore the profile of Michalina Janiszewska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
2589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tong F, Zhou W, Janiszewska M, Seath C
J Am Chem Soc
. 2025 Mar;
PMID: 40052329
Photocatalytic proximity labeling has emerged as a valuable technique for studying interactions between biomolecules in a cellular context, providing precise spatiotemporal control over protein labeling. One significant advantage of these...
2.
Yamaguchi J, Isnard P, Robil N, De La Grange P, Hoguin C, Schmitt A, et al.
J Clin Invest
. 2024 Jun;
134(15).
PMID: 38842935
Proliferative glomerulonephritis is a severe condition that often leads to kidney failure. There is a significant lack of effective treatment for these disorders. Here, following the identification of a somatic...
3.
Onubogu U, Gatenbee C, Prabhakaran S, Wolfe K, Oakes B, Salatino R, et al.
JCI Insight
. 2024 May;
9(12).
PMID: 38805346
Tumor evolution is driven by genetic variation; however, it is the tumor microenvironment (TME) that provides the selective pressure contributing to evolution in cancer. Despite high histopathological heterogeneity within glioblastoma...
4.
Janiszewska M, Tabassum D, Castano Z, Cristea S, Yamamoto K, Kingston N, et al.
Nat Cell Biol
. 2024 Mar;
26(5):841.
PMID: 38443568
No abstract available.
5.
Zorc S, Munoz-Tello P, OLeary T, Yu X, Giridhar M, Hansel-Harris A, et al.
bioRxiv
. 2024 Feb;
PMID: 38405706
IGF2BP2 (IMP2) is an RNA-binding protein that contributes to cancer tumorigenesis and metabolic disorders. Structural studies focused on individual IMP2 domains have provided important mechanistic insights into IMP2 function; however,...
6.
Zhang Y, Remillard D, Onubogu U, Karakyriakou B, Asiaban J, Ramos A, et al.
Nat Struct Mol Biol
. 2023 Jul;
30(8):1160-1171.
PMID: 37488358
Transcriptional co-regulators have been widely pursued as targets for disrupting oncogenic gene regulatory programs. However, many proteins in this target class are universally essential for cell survival, which limits their...
7.
Walentynowicz K, Engelhardt D, Cristea S, Yadav S, Onubogu U, Salatino R, et al.
Cell Rep
. 2023 Mar;
42(3):112235.
PMID: 36920905
Glioblastoma (GBM) is the most aggressive brain tumor, with a median survival of ∼15 months. Targeted approaches have not been successful in this tumor type due to the large extent...
8.
Janiszewska M, Stein S, Metzger Filho O, Eng J, Kingston N, Harper N, et al.
JCI Insight
. 2021 Apr;
6(11).
PMID: 33886505
Despite the availability of multiple human epidermal growth factor receptor 2-targeted (HER2-targeted) treatments, therapeutic resistance in HER2+ breast cancer remains a clinical challenge. Intratumor heterogeneity for HER2 and resistance-conferring mutations...
9.
Ghiaseddin A, Hoang Minh L, Janiszewska M, Shin D, Wick W, Mitchell D, et al.
Neurooncol Adv
. 2021 Feb;
3(1):vdaa145.
PMID: 33543142
Despite therapeutic advances for other malignancies, gliomas remain challenging solid tumors to treat. Complete surgical resection is nearly impossible due to gliomas' diffuse infiltrative nature, and treatment is hampered by...
10.
Hoxha S, Shepard A, Troutman S, Diao H, Doherty J, Janiszewska M, et al.
Cancer Res
. 2020 May;
80(12):2512-2522.
PMID: 32409309
The Hippo pathway regulates cell proliferation and organ size through control of the transcriptional regulators YAP (yes-associated protein) and TAZ. Upon extracellular stimuli such as cell-cell contact, the pathway negatively...